Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 15 (USP17L15) is a cysteine-type deubiquitinase enzyme that removes conjugated ubiquitin from substrate proteins, thereby regulating protein stability and participating in cellular pathways such as apoptosis, cell cycle progression, protein deubiquitination, and cellular stress responses[1][3][5][6][7][11]. USP17L15 is predicted to localize to the cytosol, nucleus, and endoplasmic reticulum, and is part of a gene family with related deubiquitinase paralogs[1][10][12]. Although its detailed tissue distribution and disease associations are not well characterized, its involvement in protein and cell cycle regulation suggests it may have broader relevance for diseases characterized by apoptosis and abnormal cell proliferation[3][7]. No specific drugs, mechanisms of action, or established biomarkers are currently documented for this target.
Enzyme inhibition (for any potential drugs, general to deubiquitinases; no specific known drugs or MOA documented)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 15 (USP17L15).